APGE R&D Expenses

Apogee Therapeutics Inc · R&D Expenses

APGE logo

APGE R&D Expenses

Latest reported$67.30M
APGE Quarterly R&D Expenses ($4.25M → $67.30M)
High-resolution chart · PNG

APGE r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Apogee Therapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
67,301,000
60,819,000
58,444,000
54,178,000
55,703,000
46,387,000
60,229,000
45,714,000
33,206,000
28,716,000
28,954,000
17,069,000
13,946,000
8,455,000
12,208,000
9,885,000
1,448,000
4,245,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.